Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIMN Liminatus Pharma LLC

Pre-Mkt 02-05 06:59:42 EST

1.43

+0.36

+33.64%

盘前1.42

-0.01-0.70%

06:59 EST

High2.10	Low1.07	Vol100.49M
Open1.15	D1 Closing1.07	Amplitude96.26%
Mkt Cap38.70M	Tradable Cap6.44M	Total Shares27.06M
T/O146.49M	T/O Rate2,230.48%	Tradable Shares4.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":1.43,"timestamp":1770238800000,"preClose":1.07,"halted":0,"volume":100487794,"hourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.43,"latestTime":"06:59 EST","volume":66431,"amount":91652.7381942,"timestamp":1770292768637,"change":-0.01,"changeRate":-0.006993,"amplitude":0.125874},"delay":0,"changeRate":0.336448598130841,"floatShares":4505200,"shares":27064633,"eps":-0.01953,"marketStatus":"Pre-Mkt","change":0.36,"latestTime":"02-05 06:59:42 EST","open":1.15,"high":2.1,"low":1.07,"amount":146490191.6542746,"amplitude":0.962617,"askPrice":1.43,"askSize":131,"bidPrice":1.42,"bidSize":290,"shortable":3,"etf":0,"ttmEps":-0.01953,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770301800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.43,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.43,"latestTime":"06:59 EST","volume":66431,"amount":91652.7381942,"timestamp":1770292768637,"change":-0.01,"changeRate":-0.006993,"amplitude":0.125874},"postHourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.43,"latestTime":"19:59 EST","volume":4268706,"amount":6310607.241,"timestamp":1770253197868,"change":0.1,"changeRate":0.06993,"amplitude":0.286713},"volumeRatio":5.4189851325521},"requestUrl":"/m/hq/s/LIMN","defaultTab":"news","newsList":[{"id":"2609394144","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:08 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394144","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609394144?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:08","pubTimestamp":1770228492,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:08 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nAQN2LKQEY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2606890229","title":"Liminatus Pharma Faces Nasdaq Delisting Risk Over Sub-$1 Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2606890229","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606890229?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:31","pubTimestamp":1769463113,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has received a notice from the Nasdaq Listing Qualifications Department indicating that the company is no longer in compliance with the Nasdaq Listing Rule 5450, which requires listed securities to maintain a minimum bid price of $1 per share. The company’s common stock has closed below this threshold for 30 consecutive business days. Liminatus has been given 180 calendar days, until July 14, 2026, to regain compliance, which can be achieved if the closing bid price meets or exceeds $1 for at least ten consecutive business days. If necessary, the company may implement a reverse stock split to meet the requirement. Failure to regain compliance could result in delisting from Nasdaq, though additional time to comply may be available.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL7lBT3x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2586785404","title":"Liminatus Pharma Faces Nasdaq Delisting Over Market Value Rule Breach","url":"https://stock-news.laohu8.com/highlight/detail?id=2586785404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586785404?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:27","pubTimestamp":1764109648,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has received notices from the Nasdaq Listing Qualifications Department indicating non-compliance with several Nasdaq listing rules. The company failed to maintain a minimum Market Value of Listed Securities of $50 million and a minimum Market Value of Publicly Held Shares of $15 million over the past 30 consecutive business days. Additionally, Liminatus does not meet requirements for total assets and revenue under another Nasdaq rule. Although these notifications do not immediately affect the company's stock listing, Liminatus is at risk of delisting if it cannot regain compliance within the prescribed timeframe. The company is actively working to address these deficiencies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL7LLTmk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2579312388","title":"Liminatus Pharma, Inc. (Nasdaq: Limn) Signs Mou With Capital Trust Group for USD 30 Million Equity Investment via an Earn-Out Mechanism and Future Strategic Cooperation","url":"https://stock-news.laohu8.com/highlight/detail?id=2579312388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579312388?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:04","pubTimestamp":1761833069,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA4CJZHK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2579123531","title":"Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation","url":"https://stock-news.laohu8.com/highlight/detail?id=2579123531","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579123531?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:04","pubTimestamp":1761833040,"startTime":"0","endTime":"0","summary":"LA PALMA, Calif., Oct.  30, 2025  (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced toda","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177589/0/en/Liminatus-Pharma-Inc-NASDAQ-LIMN-Signs-MOU-with-Capital-Trust-Group-for-USD-30-Million-Equity-Investment-via-an-earn-out-mechanism-and-Future-Strategic-Cooperation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","TSYW.SI","USJW.SI","BK4585","NVIW.SI",".IXIC","BK4215","QID","MNQmain","PSQ","LIMN","BK4588","NQmain","EQR","USD","QLD","USAW.SI","SQQQ","BK4139"],"gpt_icon":1},{"id":"2562127844","title":"Liminatus Pharma Receives Nasdaq Notice for Delayed Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2562127844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562127844?lang=en_us&edition=fundamental","pubTime":"2025-08-26 05:16","pubTimestamp":1756156573,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. , a pre-clinical stage biopharmaceutical company, announced on August 25, 2025, that it received a Nasdaq notification on August 22, 2025, for non-compliance with Listing Rule 5250 due to a delay in filing its Quarterly Report on Form 10-Q for the period ending June 30, 2025. The company's stock remains listed on Nasdaq, and it has until October 21, 2025, to submit a compliance plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2025, and is solely responsible for the information contai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL4lGcDr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2559894372","title":"Liminatus Pharma Inc. Files Initial Statement of Beneficial Ownership; Iris Acquisition Holdings LLC Named as Beneficial Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2559894372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559894372?lang=en_us&edition=fundamental","pubTime":"2025-08-16 02:50","pubTimestamp":1755283851,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. Files Initial Statement of Beneficial Ownership; Iris Acquisition Holdings LLC Named as Beneficial Owner. Liminatus Pharma Inc. has filed an initial statement of beneficial ownership, identifying Iris Acquisition Holdings LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL6GfJKs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2559916804","title":"Liminatus Pharma Inc. Announces Delay in Q2 Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2559916804","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559916804?lang=en_us&edition=fundamental","pubTime":"2025-08-15 18:34","pubTimestamp":1755254075,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has announced a delay in filing its financial report for the period ended June 30, 2025. The company filed a Notification of Late Filing  with the U.S. Securities and Exchange Commission, indicating that its Form 10-Q could not be submitted within the prescribed time frame. The delay was attributed to reasons that could not be resolved without unreasonable effort or expense.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for the information contained there","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL8WMRp7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":1.3443},{"period":"1month","weight":1.094},{"period":"3month","weight":0.1172},{"period":"6month","weight":-0.6765},{"period":"1year","weight":-0.8766},{"period":"ytd","weight":1.3443}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.012085},{"month":2,"riseRate":1,"avgChangeRate":0.332049},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065679},{"month":4,"riseRate":0.5,"avgChangeRate":-0.073295},{"month":5,"riseRate":0.25,"avgChangeRate":-0.001827},{"month":6,"riseRate":0.6,"avgChangeRate":0.20484},{"month":7,"riseRate":0.4,"avgChangeRate":-0.094814},{"month":8,"riseRate":0.2,"avgChangeRate":-0.116647},{"month":9,"riseRate":0.6,"avgChangeRate":-0.070493},{"month":10,"riseRate":0.6,"avgChangeRate":-0.032984},{"month":11,"riseRate":0.4,"avgChangeRate":-0.052841},{"month":12,"riseRate":0.6,"avgChangeRate":-0.075377}],"exchange":"NASDAQ","name":"Liminatus Pharma LLC","nameEN":"Liminatus Pharma LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liminatus Pharma LLC(LIMN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liminatus Pharma LLC,LIMN,Liminatus Pharma LLC股票,Liminatus Pharma LLC股票老虎,Liminatus Pharma LLC股票老虎国际,Liminatus Pharma LLC行情,Liminatus Pharma LLC股票行情,Liminatus Pharma LLC股价,Liminatus Pharma LLC股市,Liminatus Pharma LLC股票价格,Liminatus Pharma LLC股票交易,Liminatus Pharma LLC股票购买,Liminatus Pharma LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liminatus Pharma LLC(LIMN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}